High Risk · 27/100Apr 16, 8:19 AM EDT
Acurx Pharmaceuticals Secures $7.1 Million Through Stock Offering
ACXP
Acurx Pharmaceuticals (ACXP) has announced a definitive agreement to sell 825,085 shares of its common stock at a price of $3.03 per share, potentially raising up to $7.1 million. This capital infusion is significant for investors as it may provide the necessa…
- ▹Single-asset company with no significant regulatory or commercial news.
- ▹Recent offering indicates potential dilution risk.
High Risk · 22/100Apr 16, 7:36 AM EDT
Adlai Nortye Secures $140M in Private Placement, Shares Surge 19%
ANL
Adlai Nortye (ANL) has successfully raised $140 million through a private placement equity financing, selling approximately 11.32 million American Depositary Shares (ADSs) at $13.25 each. This significant capital injection is expected to bolster the company's…
- ▹No regulatory advancements or approvals mentioned, indicating high risk.
- ▹Private equity financing suggests potential dilution and lack of immediate commercial viability.